1.Luo J, Min S. Postoperative pain management in the postanesthesia care unit: an update. J Pain Res. 2017;10:2687-98.

https://doi.org/10.2147/JPR.S142889

PMid:29180895 PMCid:PMC5695271

2.Jastak JT, Yagiela JA. Vasoconstrictors and local anesthesia: a review and rationale for use. J Am Dent Assoc. 1983;107:623-30.

https://doi.org/10.14219/jada.archive.1983.0307

PMid:6355236 

3.Picozzi A, Neidle EA. A survey of the use of selected drugs in dental practice. J Am Dent Assoc. 1981;103:597-9.

https://doi.org/10.14219/jada.archive.1981.0300

PMid:6116727 

4.Kanazi GE, Aouad MT, Jabbour-Khoury SI, Al Jazzar MD, Alameddine MM, Al-Yaman R, et al. Effect of low-dose dexmedetomidine or clonidine on the characteristics of bupivacaine spinal block. Acta Anaesthesiol Scand. 2006;50:222-7.

https://doi.org/10.1111/j.1399-6576.2006.00919.x

PMid:16430546 

5.Calasans-Maia JA, Zapata-Sudo G, Sudo RT. Dexmedetomidine prolongs spinal anaesthesia induced by levobupivacaine 0.5% in guinea-pigs. J Pharm Pharmacol. 2005; 57:1415-20.

https://doi.org/10.1211/jpp.57.11.0006

PMid:16259773 

6.Eledjam JJ, Deschodtt J, Viel EJ, Lubrano JF, Charavel P, Françoise d'Athis, et al. Brachial plexus block with bupivacaine: effects of added alpha-adrenergic agonists: comparison between clonidine and epinephrine. Can J Anaesth. 1991;38:870-5.

https://doi.org/10.1007/BF03036962

PMid:1742820 

7.Abdallah FW, Brull R. Facilitatory effects of perineural dexmedetomidine on neuraxial and peripheral nerve block: a systematic review and meta-analysis. Br J Anaesth. 2013;110:915-25.

https://doi.org/10.1093/bja/aet066

PMid:23587874 

8.Yoshitomi T, Kohjitani A, Maeda S, Higuchi H, Shimada M, Miyawaki T. Dexmedetomidine enhances the local anesthetic action of lidocaine via an α-2a adrenoceptor. Anesth Analg. 2008;107:96-101.

https://doi.org/10.1213/ane.0b013e318176be73

PMid:18635472 

9.Singh V, Thepra M, Kirti S, Kumar P, Priya K. Dexmedetomidine as an additive to Local anesthesia: a step to development in dentistry. J Oral Maxillofac Surg. 2018;76:2091.e1-7.

https://doi.org/10.1016/j.joms.2018.05.037

PMid:29964002 

10.Vahedi Z, Moshari A, Moshari M. Efficacy of adding dexmedetomidine to lidocaine to enhance inferior alveolar nerve block in patients with asymptomatic irreversible pulpitis: double-blind randomized clinical trial. Clin Oral Investig. 2022;26:4727-34.

https://doi.org/10.1007/s00784-022-04436-7

PMid:35267097 

11.Ouchi K, Sugiyama K. Dexmedetomidine dose dependently enhances the local anesthetic action of lidocaine in inferior alveolar nerve block: a randomized double-blind study. Reg Anesth Pain Med. 2016;41:348-55.

https://doi.org/10.1097/AAP.0000000000000380

PMid:27015544 

12.Sterne JA, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M, et al. Robins-i: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ (Online). 2016;355:i4919.

https://doi.org/10.1136/bmj.i4919

PMid:27733354 PMCid:PMC5062054

13.Guyatt GH, Oxman AD, Schünemann HJ, Tugwell P, Knottnerus A. Grade guidelines: a new series of articles in the journal of clinical epidemiology. J Clin Epidemiol. 2011;64:380-2.

https://doi.org/10.1016/j.jclinepi.2010.09.011

PMid:21185693 

14.Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. Grade: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924-6.

https://doi.org/10.1136/bmj.39489.470347.AD

PMid:18436948 PMCid:PMC2335261

15.Higgins JPT, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ (Online). 2011;343:d5928.

https://doi.org/10.1136/bmj.d5928

PMid:22008217 PMCid:PMC3196245

16.Alizargar J, Etemadi Sh M, Kaviani N, Wu SFV, Jafarzadeh K, Ranjbarian P, et al. Injection of lidocaine alone versus lidocaine plus dexmedetomidine in impacted third molar extraction surgery, a double-blind randomized control trial for postoperative pain evaluation. Pain Res Manag. 2021;2021:6623792.

https://doi.org/10.1155/2021/6623792

PMid:33574974 PMCid:PMC7857915

17.Khandaitkar S, Kolte V, Shenoi SR, Budhraja N. A clinical study to determine the efficacy of 7ppm dexmedetomidine as an adjuvant to 2% lignocaine in infraorbital nerve block. Br J Oral Maxillofac Surg. 2016;54:997-1000.

https://doi.org/10.1016/j.bjoms.2016.07.011

PMid:27522312 

18.Nalawade SH, Nilesh K, Mounesh Kumar CD, Punde PA, Patil PB. A clinical comparative study of dexmedetomidine as an adjuvant to 2% plain lignocaine and 2% lignocaine with 1:200.000 adrenaline as local anesthetic agents for surgical removal of impacted mandibular third molars. Natl J Maxillofac Surg. 2021;12:255-61.

https://doi.org/10.4103/njms.NJMS_7_20

PMid:34483586 PMCid:PMC8386254

19.Patil SM, Jadhav A, Bhola N, Hingnikar P, Kshirsagar K, Patil D. Does dexmedetomidine combined with levobupivacaine in inferior alveolar nerve blocks among patients undergoing impacted third molar surgery control postoperative morbidity?. J Dent Anesth Pain Med. 2022;22:145-53.

https://doi.org/10.17245/jdapm.2022.22.2.145

PMid:35449786 PMCid:PMC8995676

20.Priyaranjan, Rohit, Dcruz TM, Patel C, Masih A, Shaik I. A comparative study evaluating the efficacy of lignocaine and dexmedetomidine with lignocaine and adrenaline in third molar surgery. J Maxillofac Oral Surg. 2020;21:634-8.

https://doi.org/10.1007/s12663-020-01477-x

PMid:35712398 PMCid:PMC9192837

21.Ouchi K. Dexmedetomidine 2 ppm is appropriate for the enhancement effect of local anesthetic action of lidocaine in inferior alveolar nerve block: a preliminary, randomized cross-over study. Clin J Pain. 2020;36:618-25.

https://doi.org/10.1097/AJP.0000000000000839

PMid:32398441 

22.Yamane A, Higuchi H, Tomoyasu Y, Ishii-Maruhama M, Maeda S, Miyawaki T. Effect of dexmedetomidine injected into the oral mucosa in combination with lidocaine on local anesthetic potency in humans: a crossover double-blind study. J Oral Maxillofac Surg. 2015;73:616-21.

https://doi.org/10.1016/j.joms.2014.09.029

PMid:25544294